Corbus Pharmaceuticals Holdings
Stock Forecast, Prediction & Price Target

Corbus Pharmaceuticals Holdings Financial Estimates

Corbus Pharmaceuticals Holdings Revenue Estimates

Corbus Pharmaceuticals Holdings EBITDA Estimates

Corbus Pharmaceuticals Holdings Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$881.70K
 
N/A
$0
 
-100%
$0
 
0%
Avg: $10M
Low: $10M
High: $10M
avg. 0%
Avg: $25M
Low: $25M
High: $25M
avg. 150%
Avg: $25M
Low: $25M
High: $25M
avg. 0%
Avg: $50M
Low: $50M
High: $50M
avg. 100%
Net Income
 
% change YoY
$-45.55M
 
N/A
$-55.83M
 
-22.56%
$-44.60M
 
20.11%
Avg: $-20.42M
Low: $-20.42M
High: $-20.42M
avg. 54.20%
Avg: $-20.74M
Low: $-20.74M
High: $-20.74M
avg. -1.55%
Avg: $-23.16M
Low: $-23.16M
High: $-23.16M
avg. -11.68%
Avg: $-25.41M
Low: $-25.41M
High: $-25.41M
avg. -9.71%
EBITDA
 
% change YoY
$-56.26M
 
N/A
$-29.50M
 
47.56%
$-44.43M
 
-50.60%
Avg: $-1.99M
Low: $-1.99M
High: $-1.99M
avg. 95.49%
Avg: $-4.99M
Low: $-4.99M
High: $-4.99M
avg. -150.00%
Avg: $-4.99M
Low: $-4.99M
High: $-4.99M
avg. 0%
Avg: $-9.99M
Low: $-9.99M
High: $-9.99M
avg. -100.00%
EPS
 
% change YoY
-$11.11
 
N/A
-$13.39
 
-20.52%
-$10.31
 
23.00%
Avg: -$4.72
Low: -$4.72
High: -$4.72
avg. 54.21%
Avg: -$4.79
Low: -$4.79
High: -$4.79
avg. -1.55%
Avg: -$5.35
Low: -$5.35
High: -$5.35
avg. -11.68%
Avg: -$5.87
Low: -$5.87
High: -$5.87
avg. -9.71%
Operating Expenses
 
% change YoY
$56.87M
 
N/A
$34.83M
 
-38.74%
$13.90M
 
-60.07%
Avg: $66.10M
Low: $66.10M
High: $66.10M
avg. 375.26%
Avg: $165.26M
Low: $165.26M
High: $165.26M
avg. 149.99%
Avg: $165.26M
Low: $165.26M
High: $165.26M
avg. 0%
Avg: $330.53M
Low: $330.53M
High: $330.53M
avg. 100.00%

FAQ

What is Corbus Pharmaceuticals Holdings stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 7.81% in 2025-2028.

We have gathered data from N/A analysts. Their low estimate is -20.42M, average is -20.42M and high is -20.42M.

What is Corbus Pharmaceuticals Holdings stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 62.5% in 2025-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $10M, average is $10M and high is $10M.

What is Corbus Pharmaceuticals Holdings stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 7.81% in 2025-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$4.72, average is -$4.72 and high is $-4.72.